A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countries von Humbert, Maria Victoria, Opurum, Precious Chinonyerem, Brendish, Nathan J, Poole, Stephen, He, Peijun, Katis, Ioannis, Quaye, Jerry, Bediako, Yaw, Duriez, Patrick Jacques, Eason, Robert W, Sones, Collin, Quaye, Osbourne, Awandare, Gordon A, Christodoulides, Myron, Clark, Tristan W, Quashie, Peter K, McCormick, Christopher J

Volltext